BLUELINX HOLDINGS INC (BXC) Fundamental Analysis & Valuation

NYSE:BXC • US09624H2085

Current stock price

55.96 USD
-0.41 (-0.73%)
At close:
55.96 USD
0 (0%)
After Hours:

This BXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BXC Profitability Analysis

1.1 Basic Checks

  • BXC had positive earnings in the past year.
  • BXC had a positive operating cash flow in the past year.
  • BXC had positive earnings in each of the past 5 years.
  • In the past 5 years BXC always reported a positive cash flow from operatings.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.01%, BXC is doing worse than 63.83% of the companies in the same industry.
  • BXC has a Return On Equity of 0.04%. This is in the lower half of the industry: BXC underperforms 65.96% of its industry peers.
  • BXC has a Return On Invested Capital of 1.69%. This is in the lower half of the industry: BXC underperforms 68.09% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BXC is below the industry average of 9.04%.
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROIC 1.69%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • The Profit Margin of BXC (0.01%) is worse than 65.96% of its industry peers.
  • In the last couple of years the Profit Margin of BXC has declined.
  • Looking at the Operating Margin, with a value of 1.02%, BXC is doing worse than 70.21% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BXC has declined.
  • Looking at the Gross Margin, with a value of 15.29%, BXC is doing worse than 89.36% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BXC has remained more or less at the same level.
Industry RankSector Rank
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BXC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BXC is destroying value.
  • Compared to 1 year ago, BXC has less shares outstanding
  • BXC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BXC is higher compared to a year ago.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • BXC has an Altman-Z score of 3.33. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
  • BXC has a Altman-Z score of 3.33. This is comparable to the rest of the industry: BXC outperforms 59.57% of its industry peers.
  • The Debt to FCF ratio of BXC is 18.81, which is on the high side as it means it would take BXC, 18.81 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BXC (18.81) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.96, BXC is doing worse than 61.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Altman-Z 3.33
ROIC/WACC0.17
WACC9.73%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • BXC has a Current Ratio of 4.66. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • BXC's Current ratio of 4.66 is amongst the best of the industry. BXC outperforms 93.62% of its industry peers.
  • BXC has a Quick Ratio of 3.12. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.12, BXC belongs to the best of the industry, outperforming 93.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 3.12
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BXC Growth Analysis

3.1 Past

  • The earnings per share for BXC have decreased strongly by -85.11% in the last year.
  • BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -35.32% yearly.
  • Looking at the last year, BXC shows a small growth in Revenue. The Revenue has grown by 0.05% in the last year.
  • The Revenue has been decreasing by -0.94% on average over the past years.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%

3.2 Future

  • BXC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 70.83% yearly.
  • Based on estimates for the next years, BXC will show a small growth in Revenue. The Revenue will grow by 4.77% on average per year.
EPS Next Y-87.95%
EPS Next 2Y70.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.44%
Revenue Next 2Y4.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. BXC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 58.91, BXC can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, BXC is valued a bit more expensive than 65.96% of the companies in the same industry.
  • BXC is valuated expensively when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 488.89, the valuation of BXC can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BXC indicates a slightly more expensive valuation: BXC is more expensive than 70.21% of the companies listed in the same industry.
  • BXC is valuated expensively when we compare the Price/Forward Earnings ratio to 37.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 58.91
Fwd PE 488.89
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

  • BXC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BXC is cheaper than 76.60% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BXC indicates a rather cheap valuation: BXC is cheaper than 93.62% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.41
EV/EBITDA 9.61
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • BXC's earnings are expected to grow with 70.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.83%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BXC Dividend Analysis

5.1 Amount

  • BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BXC Fundamentals: All Metrics, Ratios and Statistics

BLUELINX HOLDINGS INC

NYSE:BXC (4/10/2026, 8:09:15 PM)

After market: 55.96 0 (0%)

55.96

-0.41 (-0.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners100.43%
Inst Owner Change0.01%
Ins Owners2.21%
Ins Owner Change0.01%
Market Cap440.41M
Revenue(TTM)2.95B
Net Income(TTM)219.00K
Analysts77.5
Price Target72.68 (29.88%)
Short Float %5.9%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.66%
Min EPS beat(2)-23.18%
Max EPS beat(2)-10.14%
EPS beat(4)1
Avg EPS beat(4)-14.28%
Min EPS beat(4)-24.67%
Max EPS beat(4)0.88%
EPS beat(8)4
Avg EPS beat(8)9.11%
EPS beat(12)7
Avg EPS beat(12)11.85%
EPS beat(16)10
Avg EPS beat(16)12.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-2.91%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)-6.86%
PT rev (3m)-6.86%
EPS NQ rev (1m)3.36%
EPS NQ rev (3m)-92%
EPS NY rev (1m)-79.49%
EPS NY rev (3m)-93.97%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)1.29%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)1.34%
Valuation
Industry RankSector Rank
PE 58.91
Fwd PE 488.89
P/S 0.15
P/FCF 13.41
P/OCF 7.37
P/B 0.71
P/tB 0.95
EV/EBITDA 9.61
EPS(TTM)0.95
EY1.7%
EPS(NY)0.11
Fwd EY0.2%
FCF(TTM)4.17
FCFY7.46%
OCF(TTM)7.6
OCFY13.57%
SpS375.35
BVpS78.44
TBVpS58.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.95
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROCE 2.25%
ROIC 1.69%
ROICexc 2.37%
ROICexgc 2.83%
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
FCFM 1.11%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
ROICexc(3y)7.81%
ROICexc(5y)17.95%
ROICexgc(3y)8.79%
ROICexgc(5y)19.65%
ROCE(3y)6.47%
ROCE(5y)18.75%
ROICexgc growth 3Y-56.47%
ROICexgc growth 5Y-25.31%
ROICexc growth 3Y-57.61%
ROICexc growth 5Y-26.66%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
F-Score5
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Debt/EBITDA 8.51
Cap/Depr 67.49%
Cap/Sales 0.91%
Interest Coverage 0.64
Cash Conversion 85.42%
Profit Quality 15000.5%
Current Ratio 4.66
Quick Ratio 3.12
Altman-Z 3.33
F-Score5
WACC9.73%
ROIC/WACC0.17
Cap/Depr(3y)85.86%
Cap/Depr(5y)87.75%
Cap/Sales(3y)1.05%
Cap/Sales(5y)0.86%
Profit Quality(3y)5219.88%
Profit Quality(5y)3165.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y-87.95%
EPS Next 2Y70.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
Revenue Next Year4.44%
Revenue Next 2Y4.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.73%
EBIT growth 3Y-58.02%
EBIT growth 5Y-24.42%
EBIT Next Year73.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.11%
FCF growth 3Y-55.16%
FCF growth 5Y-8.53%
OCF growth 1Y-29.81%
OCF growth 3Y-46.94%
OCF growth 5Y1.68%

BLUELINX HOLDINGS INC / BXC Fundamental Analysis FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status for BXC stock?

ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


Can you provide the profitability details for BLUELINX HOLDINGS INC?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for BXC stock?

The Earnings per Share (EPS) of BLUELINX HOLDINGS INC (BXC) is expected to decline by -87.95% in the next year.